Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Recovery by Iron Following Surgery With Blood Loss, a Double-blind Multi-centre Randomized Controlled Phase III Drug Trial (the IRIS-trial)

NCT05744219 is registered in ClinicalTrials.gov with Jon Unosson as lead sponsor.

NCT NCT05744219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05744219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Recovery by Iron Following Surgery With Blood Loss, a Double-blind Multi-centre Randomized Controlled Phase III Drug Trial (the IRIS-trial)
Lead sponsor
Jon Unosson
Phase
Phase 3
Overall status
Recruiting
Start date
September 4, 2024
Completion date
March 30, 2028
Enrollment
338 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm, liver cancer, liver metastases, pancreas cancer, surgery